SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2026-06-18 12:34
Tx date 2026-06-18 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-8,400
-600 vol
$14.00 each 		177,009
Older filings
Filed 2026-06-11 16:52
Tx date 2026-06-11 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,230
-300 vol
$14.10 each 		177,609
Filed 2026-06-11 14:22
Tx date 2026-06-11 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,200
-300 vol
$14.00 each 		177,909
Filed 2026-06-11 14:20
Tx date 2026-06-10 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,200
-300 vol
$14.00 each 		178,209
Filed 2026-06-11 14:20
Tx date 2026-06-10 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,170
-300 vol
$13.90 each 		178,509
Filed 2026-06-01 09:58
Tx date 2026-05-29 		$RX
BioSyent Inc. 		BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-102,900 vol 		0
Filed 2026-06-01 09:58
Tx date 2026-05-28 		$RX
BioSyent Inc. 		BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$13,950
+1,000 vol
$13.95 each 		102,900
Filed 2026-06-01 09:57
Tx date 2026-05-27 		$RX
BioSyent Inc. 		BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$25,110
+1,800 vol
$13.95 each 		101,900
Filed 2026-06-01 09:56
Tx date 2026-05-26 		$RX
BioSyent Inc. 		BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$1,395
+100 vol
$13.95 each 		100,100
Filed 2026-06-01 09:56
Tx date 2026-05-21 		$RX
BioSyent Inc. 		BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$1,425,000
+100,000 vol
$14.25 each 		100,000
Filed 2026-05-31 17:33
Tx date 2026-05-29 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,810
-200 vol
$14.05 each 		178,809
Filed 2026-05-28 19:25
Tx date 2026-05-28 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,405
-100 vol
$14.05 each 		179,009
Filed 2026-05-26 17:26
Tx date 2026-05-26 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,230
-300 vol
$14.10 each 		179,109
Filed 2026-05-26 17:25
Tx date 2026-05-26 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,200
-300 vol
$14.00 each 		179,409
Filed 2026-05-26 17:24
Tx date 2026-05-26 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,155
-300 vol
$13.85 each 		179,709
Filed 2026-05-26 17:22
Tx date 2026-05-25 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,125
-300 vol
$13.75 each 		180,009
Filed 2026-05-07 10:50
Tx date 2025-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
30 - Acquisition or disposition under a purchase/ownership plan 		$11,877
+1,010 vol
$11.76 each 		51,620
Filed 2026-05-07 10:43
Tx date 2026-03-24 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
56 - Grant of rights
+10,884 vol 		62,504
Filed 2026-03-26 16:15
Tx date 2026-03-24 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
56 - Grant of rights
+10,844 vol
Filed 2026-03-26 16:12
Tx date 2025-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
30 - Acquisition or disposition under a purchase/ownership plan 		$10,313
+877 vol
$11.76 each